Skip to content

Prompt Approval of Safe Generic Drugs Act

In committee: it can still change before the session ends.

US HR 843 · House Bill · 119th Congress

Stage
In committee
Started in
House
Sponsor
1
Latest action
Jan 31, 2025

What it does

This bill authorizes the Food and Drug Administration (FDA) to approve certain applications to market a generic drug despite the omission of certain safety information from the generic drug's labeling.

Official summary · Introduced in House · Jan 31, 2025

Titles and provisions can change as the bill moves.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Jan 31, 2025

  2. Committee (Current step)

    In committee · Jan 31, 2025

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Prompt Approval of Safe Generic Drugs Act | 52